SI1534667T1 - Muskarinski agonisti - Google Patents
Muskarinski agonistiInfo
- Publication number
- SI1534667T1 SI1534667T1 SI200331933T SI200331933T SI1534667T1 SI 1534667 T1 SI1534667 T1 SI 1534667T1 SI 200331933 T SI200331933 T SI 200331933T SI 200331933 T SI200331933 T SI 200331933T SI 1534667 T1 SI1534667 T1 SI 1534667T1
- Authority
- SI
- Slovenia
- Prior art keywords
- muscarinic agonists
- muscarinic
- agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40544302P | 2002-08-22 | 2002-08-22 | |
| EP03792989A EP1534667B1 (en) | 2002-08-22 | 2003-08-12 | Muscarinic agonists |
| PCT/US2003/023260 WO2004018411A1 (en) | 2002-08-22 | 2003-08-12 | Muscarinic agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1534667T1 true SI1534667T1 (sl) | 2011-02-28 |
Family
ID=31946873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200331933T SI1534667T1 (sl) | 2002-08-22 | 2003-08-12 | Muskarinski agonisti |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7160922B2 (sl) |
| EP (1) | EP1534667B1 (sl) |
| JP (1) | JP4469280B2 (sl) |
| CN (1) | CN100554247C (sl) |
| AR (1) | AR040889A1 (sl) |
| AT (1) | ATE491683T1 (sl) |
| AU (1) | AU2003256791B2 (sl) |
| BR (1) | BR0313161A (sl) |
| CA (1) | CA2493958C (sl) |
| CY (1) | CY1111115T1 (sl) |
| DE (1) | DE60335380D1 (sl) |
| DK (1) | DK1534667T3 (sl) |
| ES (1) | ES2355213T3 (sl) |
| MX (1) | MXPA05002080A (sl) |
| PE (1) | PE20040894A1 (sl) |
| PT (1) | PT1534667E (sl) |
| SI (1) | SI1534667T1 (sl) |
| TW (1) | TW200410922A (sl) |
| WO (1) | WO2004018411A1 (sl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009506069A (ja) * | 2005-08-26 | 2009-02-12 | ブレインセルス，インコーポレイティド | ムスカリン性受容体調節による神経発生 |
| CN102918026A (zh) | 2010-03-29 | 2013-02-06 | 巴斯夫欧洲公司 | 杀真菌的亚氨基衍生物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002332541B2 (en) * | 2001-09-21 | 2008-05-08 | Eli Lilly And Company | Muscarinic agonists |
-
2003
- 2003-08-12 CA CA2493958A patent/CA2493958C/en not_active Expired - Fee Related
- 2003-08-12 ES ES03792989T patent/ES2355213T3/es not_active Expired - Lifetime
- 2003-08-12 DK DK03792989.0T patent/DK1534667T3/da active
- 2003-08-12 AU AU2003256791A patent/AU2003256791B2/en not_active Ceased
- 2003-08-12 WO PCT/US2003/023260 patent/WO2004018411A1/en active Application Filing
- 2003-08-12 PT PT03792989T patent/PT1534667E/pt unknown
- 2003-08-12 AT AT03792989T patent/ATE491683T1/de active
- 2003-08-12 DE DE60335380T patent/DE60335380D1/de not_active Expired - Lifetime
- 2003-08-12 JP JP2004530846A patent/JP4469280B2/ja not_active Expired - Fee Related
- 2003-08-12 US US10/524,960 patent/US7160922B2/en not_active Expired - Fee Related
- 2003-08-12 SI SI200331933T patent/SI1534667T1/sl unknown
- 2003-08-12 BR BR0313161-0A patent/BR0313161A/pt not_active IP Right Cessation
- 2003-08-12 EP EP03792989A patent/EP1534667B1/en not_active Expired - Lifetime
- 2003-08-12 CN CNB038192500A patent/CN100554247C/zh not_active Expired - Fee Related
- 2003-08-12 MX MXPA05002080A patent/MXPA05002080A/es active IP Right Grant
- 2003-08-20 AR AR20030103011A patent/AR040889A1/es unknown
- 2003-08-20 TW TW092122893A patent/TW200410922A/zh unknown
- 2003-08-21 PE PE2003000851A patent/PE20040894A1/es not_active Application Discontinuation
-
2011
- 2011-01-19 CY CY20111100057T patent/CY1111115T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003256791B2 (en) | 2008-12-11 |
| US20060122280A1 (en) | 2006-06-08 |
| MXPA05002080A (es) | 2005-08-18 |
| BR0313161A (pt) | 2005-06-14 |
| WO2004018411A1 (en) | 2004-03-04 |
| PE20040894A1 (es) | 2004-11-25 |
| PT1534667E (pt) | 2011-01-19 |
| DE60335380D1 (de) | 2011-01-27 |
| AR040889A1 (es) | 2005-04-20 |
| CA2493958C (en) | 2010-11-09 |
| US7160922B2 (en) | 2007-01-09 |
| TW200410922A (en) | 2004-07-01 |
| DK1534667T3 (da) | 2011-02-14 |
| EP1534667B1 (en) | 2010-12-15 |
| CN1675173A (zh) | 2005-09-28 |
| JP2005536549A (ja) | 2005-12-02 |
| AU2003256791A1 (en) | 2004-03-11 |
| EP1534667A1 (en) | 2005-06-01 |
| JP4469280B2 (ja) | 2010-05-26 |
| ATE491683T1 (de) | 2011-01-15 |
| CA2493958A1 (en) | 2004-03-04 |
| ES2355213T3 (es) | 2011-03-23 |
| CY1111115T1 (el) | 2015-06-11 |
| CN100554247C (zh) | 2009-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL163928A0 (en) | Pyridinoylpiperidines as 5-htf agonists | |
| HK1058196A1 (en) | Muscarinic agonists | |
| GB0206048D0 (en) | Use | |
| GB0227666D0 (en) | Use | |
| IL173521A0 (en) | Substituted 2 - carbonylamino - 6 piperidinaminopyidines and substituted 1 - carbonylamino - 3 - piperidinaminobenzenes as 5 - th1f agonists | |
| IL160751A0 (en) | Muscarinic agonists | |
| GB0203421D0 (en) | Composition | |
| GB0217056D0 (en) | Use | |
| GB0213878D0 (en) | Use | |
| GB0203280D0 (en) | Anti-glycolytic composition | |
| AU2003290818A8 (en) | Topoisomerase-targeting agents | |
| GB0206838D0 (en) | Use | |
| EP1709976A4 (en) | EMT-INDUCING MEDIUM | |
| EP1495751A4 (en) | hair dye | |
| SI1534667T1 (sl) | Muskarinski agonisti | |
| GB0230343D0 (en) | Use | |
| GB0203534D0 (en) | Muscarinic agents | |
| GB0229442D0 (en) | Use | |
| GB0203616D0 (en) | Composition | |
| GB0303623D0 (en) | Muscarinic agents | |
| AU2358P (en) | Yasflos Sutera cordata | |
| GB0204798D0 (en) | Cycostatic agents | |
| GB0212680D0 (en) | Holder | |
| GB0230038D0 (en) | Deformable-mirror holder | |
| GB0224842D0 (en) | Holder |